vs
Side-by-side financial comparison of BioNTech SE (BNTX) and F&G Annuities & Life, Inc. (FG). Click either name above to swap in a different company.
F&G Annuities & Life, Inc. is the larger business by last-quarter revenue ($1.8B vs $1.5B, roughly 1.2× BioNTech SE). F&G Annuities & Life, Inc. runs the higher net margin — 7.3% vs -1.9%, a 9.1% gap on every dollar of revenue.
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
F&G Annuities & Life, Inc. is a public company headquartered in Des Moines, Iowa. It primarily provides annuities, life insurance, and pension buyout services. The company was founded in 1959.
BNTX vs FG — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $1.8B |
| Net Profit | $-28.7M | $128.0M |
| Gross Margin | — | — |
| Operating Margin | -3.1% | — |
| Net Margin | -1.9% | 7.3% |
| Revenue YoY | — | 13.2% |
| Net Profit YoY | — | -60.9% |
| EPS (diluted) | — | $0.97 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $1.8B | ||
| Q3 25 | $1.5B | $1.7B | ||
| Q2 25 | $260.8M | $1.4B | ||
| Q1 25 | — | $908.0M | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $1.2B | $1.4B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.6B |
| Q4 25 | — | $128.0M | ||
| Q3 25 | $-28.7M | $118.0M | ||
| Q2 25 | $-386.6M | $40.0M | ||
| Q1 25 | — | $-21.0M | ||
| Q4 24 | — | $327.0M | ||
| Q3 24 | $198.1M | $-6.0M | ||
| Q2 24 | — | $203.0M | ||
| Q1 24 | — | $115.0M |
| Q4 25 | — | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -192.1% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 7.3% | ||
| Q3 25 | -1.9% | 7.0% | ||
| Q2 25 | -148.2% | 2.9% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 21.0% | ||
| Q3 24 | 15.9% | -0.4% | ||
| Q2 24 | — | 17.3% | ||
| Q1 24 | — | 7.3% |
| Q4 25 | — | $0.97 | ||
| Q3 25 | — | $0.85 | ||
| Q2 25 | — | $0.26 | ||
| Q1 25 | — | $-0.20 | ||
| Q4 24 | — | $2.53 | ||
| Q3 24 | — | $-0.08 | ||
| Q2 24 | — | $1.55 | ||
| Q1 24 | — | $0.88 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.5B |
| Total DebtLower is stronger | — | $2.2B |
| Stockholders' EquityBook value | — | $4.8B |
| Total Assets | — | $98.4B |
| Debt / EquityLower = less leverage | — | 0.47× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $3.3B | ||
| Q4 24 | — | $2.3B | ||
| Q3 24 | — | $3.5B | ||
| Q2 24 | — | $3.5B | ||
| Q1 24 | — | $2.4B |
| Q4 25 | — | $2.2B | ||
| Q3 25 | — | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.2B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | — | $4.8B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | — | $4.4B | ||
| Q1 25 | — | $4.4B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $3.7B | ||
| Q1 24 | — | $3.5B |
| Q4 25 | — | $98.4B | ||
| Q3 25 | — | $96.1B | ||
| Q2 25 | — | $91.8B | ||
| Q1 25 | — | $88.0B | ||
| Q4 24 | — | $85.0B | ||
| Q3 24 | — | $84.1B | ||
| Q2 24 | — | $78.5B | ||
| Q1 24 | — | $74.4B |
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 0.46× | ||
| Q2 25 | — | 0.50× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.56× | ||
| Q1 24 | — | 0.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $1.2B |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 9.13× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $937.0M | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $956.0M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.5B |
| Q4 25 | — | 9.13× | ||
| Q3 25 | — | 7.94× | ||
| Q2 25 | — | 40.50× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.04× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.20× | ||
| Q1 24 | — | 13.34× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
